Creo Medical Group (CREO)

Sector:

Health Care

Index:

FTSE AIM All-Share

10.88p
   
  • Change Today:
    -0.13p
  • 52 Week High: 19.75p
  • 52 Week Low: 9.55p
  • Currency: UK Pounds
  • Shares Issued: 412.47m
  • Volume: 200,304
  • Market Cap: £44.86m
  • Beta: 0.56

CREO Overview

Creo Medical was founded in 2003 as MicroOncology Ltd by Professor Chris Hancock, initially to target the treatment of cancers through use of high frequency microwave energy and dynamic matching techniques.

Key Personnel

CEO: Craig Jonathan Gulliford
CFO: Richard John Rees
Chairman: Kevin Crofton
Independent Non-Executive Director: Ivonne Cantu
Independent Non-Executive Director: Brent Boucher
Non-Executive Dir:

Contact Details

Address: Creo House, Unit 2 Beaufort Park, Beaufort Park Way, Chepstow, Wales, United Kingdom , NP16 5UH
Phone: +44 (0) 1291 606005
Website: http://creomedical.com/

Listings

Sector: Health Care(LSE)
Index: FTSE AIM All-Share
ISIN: GB00BZ1BLL44

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

 

CREO Market Data

Currency UK Pounds
Share Price 10.88p
Change Today -0.13p
% Change -1.14 %
52 Week High 19.75p
52 Week Low 9.55p
Volume 200,304
Shares Issued 412.47m
Market Cap £44.86m
Beta 0.56

CREO Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
5.70% above the market average5.70% above the market average5.70% above the market average5.70% above the market average5.70% above the market average
9.09% below the sector average9.09% below the sector average9.09% below the sector average9.09% below the sector average9.09% below the sector average
Price Trend
76.94% below the market average76.94% below the market average76.94% below the market average76.94% below the market average76.94% below the market average
31.43% below the sector average31.43% below the sector average31.43% below the sector average31.43% below the sector average31.43% below the sector average
Income Not Available
Growth
46.91% below the market average46.91% below the market average46.91% below the market average46.91% below the market average46.91% below the market average
65.71% below the sector average65.71% below the sector average65.71% below the sector average65.71% below the sector average65.71% below the sector average

CREO Dividends

No dividends found

Trades for 14-Jan-2026

Time Volume / Share Price
12:15 179,304 @ 11.15p
09:51 21,000 @ 10.93p

CREO Key Personnel

CEO Craig Jonathan Gulliford
CFO Richard John Rees
Chair Kevin Crofton

Top of Page